DRUG BRIGHT MINDS BIOSCIENCES INC.: institutional ownership and insider trading

107 funds reported holding $751M of BRIGHT MINDS BIOSCIENCES INC. in their latest 13F filings; in Q2 2026 funds net bought $4.06M, with 18 new positions and 12 funds selling out; over the last 12 months insiders bought $0 and sold $9.79M on the open market.

Famous investors holding DRUG

Largest institutional holders of DRUG

  1. Jupiter Topco LLC — $94.8M
  2. JANUS HENDERSON GROUP PLC (JHG) — $93.5M
  3. Cormorant Asset Management, LP — $63.2M
  4. BlackRock, Inc. (BLK) — $48.2M
  5. Vivo Capital, LLC — $39.1M
  6. Vestal Point Capital, LP — $38.3M
  7. BRAIDWELL LP — $34.0M
  8. DRIEHAUS CAPITAL MANAGEMENT LLC — $30.4M
  9. BALYASNY ASSET MANAGEMENT L.P. — $24.2M
  10. ADAGE CAPITAL PARTNERS GP, L.L.C. — $23.5M

Recent DRUG insider trades

5%+ owners

Who owns the most DRUG stock?

The largest institutional holders of BRIGHT MINDS BIOSCIENCES INC. in the latest 13F filings are Jupiter Topco LLC ($94.8M), JANUS HENDERSON GROUP PLC (JHG) ($93.5M), Cormorant Asset Management, LP ($63.2M).

Are insiders buying or selling DRUG?

Over the last 12 months insiders bought $0 and sold $9.79M of BRIGHT MINDS BIOSCIENCES INC. stock on the open market (SEC Form 4).

Which famous investors own DRUG?

Izzy Englander, Ken Griffin, Two Sigma.

Which ETFs hold DRUG?

5 ETFs and mutual funds hold it among their top 100 positions, including ETAHX, SHISX, DMCRX, PSIL.

All DRUG 13F holders · All DRUG insider trades